Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
Aim. To study effectiveness of ACE inhibitor therapy in coronary heart disease (CHD) combined with chronic obstructive pulmonary disease (COPD). Material and methods. In total, 89 males with CHD and COPD were examined. All participants had Stage I-II arterial hypertension (AH). For antihypertensive...
| Published in: | Кардиоваскулярная терапия и профилактика |
|---|---|
| Main Authors: | M. A. Popova, N. N. Terentyeva |
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2006-06-01
|
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1196 |
Similar Items
Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure
by: S, Yu. Volkova, et al.
Published: (2006-08-01)
by: S, Yu. Volkova, et al.
Published: (2006-08-01)
ACE inhibitor fosinopril in the treatment of hypertension: potential benefits
by: AO Konradi
Published: (2014-12-01)
by: AO Konradi
Published: (2014-12-01)
Comparative efficacy of ace inhibitor spirapril in hypertensive patients from various age groups
by: L. A. Sokolova, et al.
Published: (2006-06-01)
by: L. A. Sokolova, et al.
Published: (2006-06-01)
Clinical, cardio-hemodynamical, and respiratory effects of ACE inhibitor cilazapril in patients with arterial hypertension and chronic obstructive pulmonary disease
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)
Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)
by: G. A. Baryshnikova
Published: (2007-12-01)
FORECASTING CORONARY EVENTS BASED ON THE ANALYSIS OF THE DYNAMICS OF MORPHOFUNCTIONAL PARAMETERS OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE NORTH
by: D. A. Dolgopolova, et al.
Published: (2018-02-01)
by: D. A. Dolgopolova, et al.
Published: (2018-02-01)
Coronary artery status in patients with coronary heart disease and chronic obstructive pulmonary disease: results of selective coronary angiography
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)
The role of fosinopril in the treatment and prevention of cardiovascular diseases
by: G. A. Baryshnikova
Published: (2015-12-01)
by: G. A. Baryshnikova
Published: (2015-12-01)
Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery
by: Yu. M. Lopatin, et al.
Published: (2009-06-01)
by: Yu. M. Lopatin, et al.
Published: (2009-06-01)
A ROLE OF ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SUMMARY
by: N. D. Elshin, et al.
Published: (2017-09-01)
by: N. D. Elshin, et al.
Published: (2017-09-01)
Dynamics of characteristics of respiratory function for the development of coronary heart disease in patients with chronic obstructive lung disease
by: D. A. Vishnyak, et al.
Published: (2019-03-01)
by: D. A. Vishnyak, et al.
Published: (2019-03-01)
ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)
by: M. A. Popova, et al.
Published: (2015-12-01)
Comparative analysis of prothrombotic activity in patients with myocardial infarction with and without obstructive coronary artery disease
by: D. A. Vorobieva, et al.
Published: (2021-03-01)
by: D. A. Vorobieva, et al.
Published: (2021-03-01)
The prevalence of obstructive airway disease by spirometric indices in nonsmoker patients with catheter-diagnosed coronary artery disease
by: Ankur Agrawal, et al.
Published: (2019-01-01)
by: Ankur Agrawal, et al.
Published: (2019-01-01)
Coronary microvascular dysfunction. Diagnostics and therapy of non-obstructive coronary diseases
by: Ipoly Szauder
Published: (2024-08-01)
by: Ipoly Szauder
Published: (2024-08-01)
An Evaluation of the Role of Oxidative Stress in Non-Obstructive Coronary Artery Disease
by: Nurnajwa Pahimi, et al.
Published: (2022-02-01)
by: Nurnajwa Pahimi, et al.
Published: (2022-02-01)
Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)
Predictive value of machine learning algorithm of coronary artery calcium score and clinical factors for obstructive coronary artery disease in hypertensive patients
by: Minxian Wang, et al.
Published: (2023-10-01)
by: Minxian Wang, et al.
Published: (2023-10-01)
Enalapril effects on renal function and ACE gene polymorphism in hypertensive nephropathy
by: K. Y. Zholdoshov, et al.
Published: (2010-10-01)
by: K. Y. Zholdoshov, et al.
Published: (2010-10-01)
Evaluating chronopharmacological effectiveness of fosinopril and its combination with melatonin in elderly patients with hypertension and coronary artery disease
by: O. A. Lednev
Published: (2014-12-01)
by: O. A. Lednev
Published: (2014-12-01)
Clinical aspects of ischemia with no obstructive coronary artery disease (INOCA)
by: Alexander Polyak, et al.
Published: (2024-01-01)
by: Alexander Polyak, et al.
Published: (2024-01-01)
Association of ACE gene polymorphisms with cardiovascular events in patients after elective percutaneous coronary interventions
by: E. O. Nalesnik, et al.
Published: (2022-11-01)
by: E. O. Nalesnik, et al.
Published: (2022-11-01)
ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)
by: O. D. Ostroumova, et al.
Published: (1970-01-01)
COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)
Objective Ischemia, Subjective Angina, and Psychological Distress in Angina With No Obstructive Coronary Disease
by: Yuting Liu, et al.
Published: (2024-08-01)
by: Yuting Liu, et al.
Published: (2024-08-01)
The Association of Severe Coronary Tortuosity and Non-Obstructive Coronary Artery Disease
by: Petra Zebic Mihic, et al.
Published: (2023-09-01)
by: Petra Zebic Mihic, et al.
Published: (2023-09-01)
Influence of chronic obstructive pulmonary disease on hospital outcomes of percutaneous coronary interventions in patients with acute coronary syndrome
by: Alexey A. Frolov, et al.
Published: (2024-04-01)
by: Alexey A. Frolov, et al.
Published: (2024-04-01)
Predictors and Prevalence of Obstructive Coronary Artery Disease in Patients Who Underwent Elective Invasive Coronary Angiography for Chronic Coronary Syndrome [Letter]
by: Nugroho HSW
Published: (2024-05-01)
by: Nugroho HSW
Published: (2024-05-01)
Inflammatory Activity in Patients with Obstructive and Non-obstructive Coronary Artery Disease
by: N. N. Pakhtusov, et al.
Published: (2023-03-01)
by: N. N. Pakhtusov, et al.
Published: (2023-03-01)
Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)
by: T. E. Morozova, et al.
Published: (2013-08-01)
New perspectives in coronary heart disease management
by: V. I. Makolkin
Published: (2005-02-01)
by: V. I. Makolkin
Published: (2005-02-01)
Osteopontin in patients with chronic obstructive pulmonary disease and coronary heart disease
by: Natalia A. Suvorova, et al.
Published: (2023-05-01)
by: Natalia A. Suvorova, et al.
Published: (2023-05-01)
Ischemia with No Obstructive Coronary Artery Disease (INOCA): A Review
by: Laura Viola, et al.
Published: (2025-10-01)
by: Laura Viola, et al.
Published: (2025-10-01)
Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)
by: V. M. Gorbunov
Published: (2005-06-01)
Manifestations of Cellular Anomalies of Gingival Epithelium in Patients with Chronic Obstructive Pulmonary Diseases Combined with Coronary Heart Disease
by: Emelyanova N.
Published: (2017-09-01)
by: Emelyanova N.
Published: (2017-09-01)
Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)
by: D. P. Khloponin, et al.
Published: (2007-10-01)
Investigation of the Mechanism and Effect of Enalapril, Angiotensin-Converting Enzyme (ACE) Inhibitor, on Proliferation, Apoptosis, and Migration in Colorectal Cancer Cells
by: Asma Mostafapour, et al.
Published: (2020-08-01)
by: Asma Mostafapour, et al.
Published: (2020-08-01)
Prognostic value of non-obstructive coronary artery disease based on coronary computed tomography angiography in a long-term follow-up and multicenter study
by: Zengfa Huang, et al.
Published: (2025-05-01)
by: Zengfa Huang, et al.
Published: (2025-05-01)
IVABRADINE EFFECTIVENESS IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
by: I. V. Kochetkova, et al.
Published: (2014-04-01)
by: I. V. Kochetkova, et al.
Published: (2014-04-01)
Comparative assessment of echocardiographic parameters, including the left ventricular global function index in patients with myocardial infarction with obstructive (MICAD) and non-obstructive coronary artery disease (MINOCA)
by: N. I. Maksimov, et al.
Published: (2025-03-01)
by: N. I. Maksimov, et al.
Published: (2025-03-01)
Similar Items
-
Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure
by: S, Yu. Volkova, et al.
Published: (2006-08-01) -
ACE inhibitor fosinopril in the treatment of hypertension: potential benefits
by: AO Konradi
Published: (2014-12-01) -
Comparative efficacy of ace inhibitor spirapril in hypertensive patients from various age groups
by: L. A. Sokolova, et al.
Published: (2006-06-01) -
Clinical, cardio-hemodynamical, and respiratory effects of ACE inhibitor cilazapril in patients with arterial hypertension and chronic obstructive pulmonary disease
by: L. I. Olbynskaya, et al.
Published: (2005-02-01) -
Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)
